Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH

This study has been completed.
Information provided by:
Ferring Pharmaceuticals Identifier:
First received: February 23, 2006
Last updated: May 18, 2011
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2005
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)